FSAP Marburg I polymorphism in the study population
. | Patients, no. (%) . | Controls, no. (%) . | Crude odds ratio (95% CI) . | Adjusted odds ratio*(95% CI) . |
|---|---|---|---|---|
| All VTE | 21 (5.3) | 21 (5.2) | 1.0 (0.5-1.9) | 1.0 (0.51-1.9) |
| Idiopathic VTE | 8 (4.4) | 21 (5.2) | 0.8 (0.4-1.9) | 1.1 (0.5-2.7) |
. | Patients, no. (%) . | Controls, no. (%) . | Crude odds ratio (95% CI) . | Adjusted odds ratio*(95% CI) . |
|---|---|---|---|---|
| All VTE | 21 (5.3) | 21 (5.2) | 1.0 (0.5-1.9) | 1.0 (0.51-1.9) |
| Idiopathic VTE | 8 (4.4) | 21 (5.2) | 0.8 (0.4-1.9) | 1.1 (0.5-2.7) |
CI indicates confidence interval.
Adjusted for age, sex, and the presence of thrombophilia